nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Dactinomycin—uterine cancer	0.0963	0.14	CbGbCtD
Pantoprazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0681	0.0988	CbGbCtD
Pantoprazole—ABCG2—Carboplatin—uterine cancer	0.0647	0.0939	CbGbCtD
Pantoprazole—ABCG2—Etoposide—uterine cancer	0.0543	0.0788	CbGbCtD
Pantoprazole—CYP2C19—Progesterone—uterine cancer	0.0543	0.0787	CbGbCtD
Pantoprazole—CYP1A2—Progesterone—uterine cancer	0.0501	0.0726	CbGbCtD
Pantoprazole—CYP2C9—Progesterone—uterine cancer	0.0451	0.0654	CbGbCtD
Pantoprazole—ABCB1—Progesterone—uterine cancer	0.0438	0.0635	CbGbCtD
Pantoprazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0396	0.0574	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—uterine cancer	0.0371	0.0538	CbGbCtD
Pantoprazole—ABCB1—Dactinomycin—uterine cancer	0.0347	0.0504	CbGbCtD
Pantoprazole—CYP3A4—Progesterone—uterine cancer	0.0262	0.0381	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—uterine cancer	0.0224	0.0325	CbGbCtD
Pantoprazole—ABCB1—Etoposide—uterine cancer	0.0196	0.0284	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—uterine cancer	0.0134	0.0194	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—uterine cancer	0.0117	0.017	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—uterine cancer	0.00801	0.0116	CbGbCtD
Pantoprazole—Omeprazole—CYP11A1—uterine cancer	0.00389	1	CrCbGaD
Pantoprazole—ATP4A—epithelium—uterine cancer	0.000939	0.12	CbGeAlD
Pantoprazole—ATP4A—renal system—uterine cancer	0.000871	0.111	CbGeAlD
Pantoprazole—ATP4A—female reproductive system—uterine cancer	0.000698	0.0889	CbGeAlD
Pantoprazole—SLCO1B1—renal system—uterine cancer	0.000467	0.0595	CbGeAlD
Pantoprazole—SLCO1B1—female reproductive system—uterine cancer	0.000374	0.0476	CbGeAlD
Pantoprazole—ABCG2—myometrium—uterine cancer	0.000355	0.0452	CbGeAlD
Pantoprazole—ABCG2—uterine cervix—uterine cancer	0.000276	0.0352	CbGeAlD
Pantoprazole—ABCG2—decidua—uterine cancer	0.000263	0.0335	CbGeAlD
Pantoprazole—ABCG2—endometrium—uterine cancer	0.00025	0.0318	CbGeAlD
Pantoprazole—CYP1A2—renal system—uterine cancer	0.000248	0.0317	CbGeAlD
Pantoprazole—ABCG2—mammalian vulva—uterine cancer	0.000241	0.0308	CbGeAlD
Pantoprazole—ABCG2—uterus—uterine cancer	0.00023	0.0293	CbGeAlD
Pantoprazole—CYP2C19—vagina—uterine cancer	0.00022	0.0281	CbGeAlD
Pantoprazole—CYP2C9—female reproductive system—uterine cancer	0.000189	0.0241	CbGeAlD
Pantoprazole—ABCG2—female gonad—uterine cancer	0.000188	0.024	CbGeAlD
Pantoprazole—ABCG2—vagina—uterine cancer	0.000187	0.0238	CbGeAlD
Pantoprazole—CYP3A4—renal system—uterine cancer	0.00018	0.0229	CbGeAlD
Pantoprazole—ABCB1—myometrium—uterine cancer	0.000175	0.0223	CbGeAlD
Pantoprazole—CYP3A4—female reproductive system—uterine cancer	0.000144	0.0184	CbGeAlD
Pantoprazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000139	0.000464	CcSEcCtD
Pantoprazole—Dysuria—Epirubicin—uterine cancer	0.000137	0.00046	CcSEcCtD
Pantoprazole—ABCB1—epithelium—uterine cancer	0.000137	0.0175	CbGeAlD
Pantoprazole—Abdominal distension—Doxorubicin—uterine cancer	0.000137	0.000458	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000137	0.000457	CcSEcCtD
Pantoprazole—ABCB1—uterine cervix—uterine cancer	0.000136	0.0173	CbGeAlD
Pantoprazole—Dysphagia—Doxorubicin—uterine cancer	0.000136	0.000455	CcSEcCtD
Pantoprazole—Asthma—Doxorubicin—uterine cancer	0.000136	0.000455	CcSEcCtD
Pantoprazole—Influenza—Doxorubicin—uterine cancer	0.000136	0.000455	CcSEcCtD
Pantoprazole—Pollakiuria—Epirubicin—uterine cancer	0.000136	0.000454	CcSEcCtD
Pantoprazole—Eosinophilia—Doxorubicin—uterine cancer	0.000135	0.00045	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.000134	0.000449	CcSEcCtD
Pantoprazole—Paraesthesia—Etoposide—uterine cancer	0.000134	0.000448	CcSEcCtD
Pantoprazole—Weight increased—Epirubicin—uterine cancer	0.000134	0.000447	CcSEcCtD
Pantoprazole—Pancreatitis—Doxorubicin—uterine cancer	0.000133	0.000446	CcSEcCtD
Pantoprazole—Weight decreased—Epirubicin—uterine cancer	0.000133	0.000445	CcSEcCtD
Pantoprazole—Dyspnoea—Etoposide—uterine cancer	0.000133	0.000445	CcSEcCtD
Pantoprazole—Hyperglycaemia—Epirubicin—uterine cancer	0.000133	0.000443	CcSEcCtD
Pantoprazole—Somnolence—Etoposide—uterine cancer	0.000133	0.000443	CcSEcCtD
Pantoprazole—Angina pectoris—Doxorubicin—uterine cancer	0.000132	0.000443	CcSEcCtD
Pantoprazole—Pneumonia—Epirubicin—uterine cancer	0.000132	0.000441	CcSEcCtD
Pantoprazole—Infestation NOS—Epirubicin—uterine cancer	0.000131	0.000438	CcSEcCtD
Pantoprazole—Infestation—Epirubicin—uterine cancer	0.000131	0.000438	CcSEcCtD
Pantoprazole—Vomiting—Dactinomycin—uterine cancer	0.000131	0.000438	CcSEcCtD
Pantoprazole—Bronchitis—Doxorubicin—uterine cancer	0.000131	0.000437	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00013	0.000434	CcSEcCtD
Pantoprazole—Rash—Dactinomycin—uterine cancer	0.00013	0.000434	CcSEcCtD
Pantoprazole—ABCB1—decidua—uterine cancer	0.00013	0.0165	CbGeAlD
Pantoprazole—Decreased appetite—Etoposide—uterine cancer	0.00013	0.000433	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—uterine cancer	0.000129	0.000432	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000129	0.00043	CcSEcCtD
Pantoprazole—Fatigue—Etoposide—uterine cancer	0.000129	0.00043	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000128	0.00043	CcSEcCtD
Pantoprazole—Stomatitis—Epirubicin—uterine cancer	0.000128	0.000427	CcSEcCtD
Pantoprazole—Jaundice—Epirubicin—uterine cancer	0.000128	0.000427	CcSEcCtD
Pantoprazole—Constipation—Etoposide—uterine cancer	0.000127	0.000426	CcSEcCtD
Pantoprazole—Pain—Etoposide—uterine cancer	0.000127	0.000426	CcSEcCtD
Pantoprazole—Urinary tract infection—Epirubicin—uterine cancer	0.000127	0.000426	CcSEcCtD
Pantoprazole—Conjunctivitis—Epirubicin—uterine cancer	0.000127	0.000426	CcSEcCtD
Pantoprazole—ABCB1—renal system—uterine cancer	0.000127	0.0162	CbGeAlD
Pantoprazole—Dysuria—Doxorubicin—uterine cancer	0.000127	0.000425	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000126	0.000423	CcSEcCtD
Pantoprazole—Sweating—Epirubicin—uterine cancer	0.000126	0.00042	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—uterine cancer	0.000126	0.00042	CcSEcCtD
Pantoprazole—Haematuria—Epirubicin—uterine cancer	0.000125	0.000418	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000124	0.000415	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000124	0.000414	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—uterine cancer	0.000124	0.000414	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—uterine cancer	0.000124	0.000413	CcSEcCtD
Pantoprazole—ABCB1—endometrium—uterine cancer	0.000123	0.0157	CbGeAlD
Pantoprazole—Weight decreased—Doxorubicin—uterine cancer	0.000123	0.000411	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—uterine cancer	0.000123	0.000411	CcSEcCtD
Pantoprazole—Feeling abnormal—Etoposide—uterine cancer	0.000123	0.000411	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—uterine cancer	0.000123	0.00041	CcSEcCtD
Pantoprazole—Nausea—Dactinomycin—uterine cancer	0.000122	0.000409	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—uterine cancer	0.000122	0.000409	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—uterine cancer	0.000122	0.000408	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000122	0.000408	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—uterine cancer	0.000121	0.000406	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—uterine cancer	0.000121	0.000406	CcSEcCtD
Pantoprazole—ABCG2—lymph node—uterine cancer	0.000121	0.0154	CbGeAlD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00012	0.000402	CcSEcCtD
Pantoprazole—ABCB1—mammalian vulva—uterine cancer	0.000119	0.0152	CbGeAlD
Pantoprazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000119	0.000397	CcSEcCtD
Pantoprazole—Urticaria—Etoposide—uterine cancer	0.000118	0.000396	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—uterine cancer	0.000118	0.000395	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—uterine cancer	0.000118	0.000395	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—uterine cancer	0.000118	0.000395	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—uterine cancer	0.000118	0.000394	CcSEcCtD
Pantoprazole—Abdominal pain—Etoposide—uterine cancer	0.000118	0.000394	CcSEcCtD
Pantoprazole—Body temperature increased—Etoposide—uterine cancer	0.000118	0.000394	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000118	0.000394	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—uterine cancer	0.000118	0.000394	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—uterine cancer	0.000118	0.000393	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—uterine cancer	0.000118	0.000393	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—uterine cancer	0.000117	0.000391	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—uterine cancer	0.000117	0.00039	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—uterine cancer	0.000116	0.000389	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000116	0.000389	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—uterine cancer	0.000116	0.000388	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—uterine cancer	0.000116	0.000387	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000116	0.000387	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—uterine cancer	0.000115	0.000386	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000115	0.000384	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—uterine cancer	0.000114	0.000382	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—uterine cancer	0.000114	0.00038	CcSEcCtD
Pantoprazole—ABCB1—uterus—uterine cancer	0.000113	0.0144	CbGeAlD
Pantoprazole—Visual impairment—Epirubicin—uterine cancer	0.000113	0.000379	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000113	0.000378	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—uterine cancer	0.000111	0.000372	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—uterine cancer	0.00011	0.000368	CcSEcCtD
Pantoprazole—Hypersensitivity—Etoposide—uterine cancer	0.00011	0.000367	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—uterine cancer	0.00011	0.000367	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—uterine cancer	0.000109	0.000366	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—uterine cancer	0.000109	0.000365	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—uterine cancer	0.000109	0.000365	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—uterine cancer	0.000109	0.000364	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—uterine cancer	0.000109	0.000364	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—uterine cancer	0.000108	0.000362	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—uterine cancer	0.000108	0.000361	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000107	0.000359	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—uterine cancer	0.000107	0.000359	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—uterine cancer	0.000107	0.000358	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—uterine cancer	0.000107	0.000358	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—uterine cancer	0.000107	0.000357	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—uterine cancer	0.000106	0.000355	CcSEcCtD
Pantoprazole—Chills—Epirubicin—uterine cancer	0.000106	0.000353	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—uterine cancer	0.000105	0.000353	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—uterine cancer	0.000105	0.000351	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—uterine cancer	0.000105	0.000351	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—uterine cancer	0.000104	0.000348	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—uterine cancer	0.000103	0.000345	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000103	0.000344	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—uterine cancer	0.000102	0.000342	CcSEcCtD
Pantoprazole—Diarrhoea—Etoposide—uterine cancer	0.000102	0.000341	CcSEcCtD
Pantoprazole—ABCB1—female reproductive system—uterine cancer	0.000102	0.013	CbGeAlD
Pantoprazole—Eye disorder—Doxorubicin—uterine cancer	0.000102	0.00034	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—uterine cancer	0.000101	0.000339	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—uterine cancer	0.000101	0.000338	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—uterine cancer	0.000101	0.000337	CcSEcCtD
Pantoprazole—Tension—Epirubicin—uterine cancer	0.0001	0.000336	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—uterine cancer	0.0001	0.000335	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—uterine cancer	9.95e-05	0.000333	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—uterine cancer	9.91e-05	0.000331	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—uterine cancer	9.86e-05	0.00033	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—uterine cancer	9.85e-05	0.000329	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—uterine cancer	9.83e-05	0.000329	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—uterine cancer	9.77e-05	0.000327	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—uterine cancer	9.72e-05	0.000325	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—uterine cancer	9.65e-05	0.000323	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—uterine cancer	9.62e-05	0.000322	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—uterine cancer	9.54e-05	0.000319	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—uterine cancer	9.5e-05	0.000318	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—uterine cancer	9.48e-05	0.000317	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—uterine cancer	9.47e-05	0.000317	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—uterine cancer	9.46e-05	0.000317	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—uterine cancer	9.41e-05	0.000315	CcSEcCtD
Pantoprazole—Rash—Etoposide—uterine cancer	9.4e-05	0.000314	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—uterine cancer	9.39e-05	0.000314	CcSEcCtD
Pantoprazole—Headache—Etoposide—uterine cancer	9.34e-05	0.000312	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—uterine cancer	9.34e-05	0.000312	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—uterine cancer	9.3e-05	0.000311	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—uterine cancer	9.28e-05	0.00031	CcSEcCtD
Pantoprazole—ABCB1—female gonad—uterine cancer	9.28e-05	0.0118	CbGeAlD
Pantoprazole—Malaise—Epirubicin—uterine cancer	9.23e-05	0.000309	CcSEcCtD
Pantoprazole—ABCB1—vagina—uterine cancer	9.22e-05	0.0117	CbGeAlD
Pantoprazole—Nervousness—Doxorubicin—uterine cancer	9.2e-05	0.000308	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—uterine cancer	9.2e-05	0.000308	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—uterine cancer	9.18e-05	0.000307	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—uterine cancer	9.17e-05	0.000307	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—uterine cancer	9.17e-05	0.000307	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—uterine cancer	9.11e-05	0.000305	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—uterine cancer	9.05e-05	0.000303	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—uterine cancer	9e-05	0.000301	CcSEcCtD
Pantoprazole—Cough—Epirubicin—uterine cancer	8.94e-05	0.000299	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—uterine cancer	8.93e-05	0.000299	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—uterine cancer	8.87e-05	0.000297	CcSEcCtD
Pantoprazole—Nausea—Etoposide—uterine cancer	8.86e-05	0.000296	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—uterine cancer	8.84e-05	0.000296	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—uterine cancer	8.79e-05	0.000294	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—uterine cancer	8.76e-05	0.000293	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—uterine cancer	8.72e-05	0.000292	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—uterine cancer	8.72e-05	0.000292	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—uterine cancer	8.72e-05	0.000292	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—uterine cancer	8.71e-05	0.000291	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—uterine cancer	8.69e-05	0.000291	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	8.66e-05	0.00029	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—uterine cancer	8.61e-05	0.000288	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—uterine cancer	8.54e-05	0.000286	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—uterine cancer	8.53e-05	0.000285	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—uterine cancer	8.51e-05	0.000285	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—uterine cancer	8.5e-05	0.000284	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—uterine cancer	8.48e-05	0.000284	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—uterine cancer	8.43e-05	0.000282	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—uterine cancer	8.37e-05	0.00028	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—uterine cancer	8.36e-05	0.00028	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—uterine cancer	8.36e-05	0.00028	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—uterine cancer	8.33e-05	0.000279	CcSEcCtD
Pantoprazole—Infection—Epirubicin—uterine cancer	8.3e-05	0.000278	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—uterine cancer	8.27e-05	0.000277	CcSEcCtD
Pantoprazole—Shock—Epirubicin—uterine cancer	8.22e-05	0.000275	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—uterine cancer	8.21e-05	0.000275	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—uterine cancer	8.2e-05	0.000274	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—uterine cancer	8.18e-05	0.000274	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—uterine cancer	8.18e-05	0.000274	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—uterine cancer	8.16e-05	0.000273	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—uterine cancer	8.12e-05	0.000271	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—uterine cancer	8.08e-05	0.00027	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—uterine cancer	8.07e-05	0.00027	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—uterine cancer	8.07e-05	0.00027	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—uterine cancer	8.07e-05	0.00027	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—uterine cancer	8.04e-05	0.000269	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	8.01e-05	0.000268	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—uterine cancer	7.97e-05	0.000267	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—uterine cancer	7.97e-05	0.000266	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—uterine cancer	7.89e-05	0.000264	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—uterine cancer	7.81e-05	0.000261	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—uterine cancer	7.8e-05	0.000261	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—uterine cancer	7.73e-05	0.000259	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—uterine cancer	7.73e-05	0.000259	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—uterine cancer	7.68e-05	0.000257	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	7.61e-05	0.000255	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—uterine cancer	7.61e-05	0.000254	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—uterine cancer	7.58e-05	0.000254	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—uterine cancer	7.57e-05	0.000253	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—uterine cancer	7.56e-05	0.000253	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—uterine cancer	7.55e-05	0.000252	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—uterine cancer	7.51e-05	0.000251	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—uterine cancer	7.5e-05	0.000251	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—uterine cancer	7.48e-05	0.00025	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—uterine cancer	7.45e-05	0.000249	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—uterine cancer	7.43e-05	0.000248	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—uterine cancer	7.37e-05	0.000247	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—uterine cancer	7.36e-05	0.000246	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—uterine cancer	7.26e-05	0.000243	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—uterine cancer	7.23e-05	0.000242	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—uterine cancer	7.22e-05	0.000241	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—uterine cancer	7.21e-05	0.000241	CcSEcCtD
Pantoprazole—Pain—Epirubicin—uterine cancer	7.15e-05	0.000239	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—uterine cancer	7.15e-05	0.000239	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.05e-05	0.000236	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—uterine cancer	6.99e-05	0.000234	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—uterine cancer	6.94e-05	0.000232	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—uterine cancer	6.89e-05	0.000231	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—uterine cancer	6.89e-05	0.00023	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—uterine cancer	6.87e-05	0.00023	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—uterine cancer	6.83e-05	0.000229	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—uterine cancer	6.81e-05	0.000228	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—uterine cancer	6.72e-05	0.000225	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.68e-05	0.000223	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—uterine cancer	6.67e-05	0.000223	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—uterine cancer	6.64e-05	0.000222	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—uterine cancer	6.61e-05	0.000221	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—uterine cancer	6.61e-05	0.000221	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—uterine cancer	6.61e-05	0.000221	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—uterine cancer	6.61e-05	0.000221	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—uterine cancer	6.37e-05	0.000213	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—uterine cancer	6.32e-05	0.000211	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—uterine cancer	6.16e-05	0.000206	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—uterine cancer	6.14e-05	0.000205	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—uterine cancer	6.11e-05	0.000204	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—uterine cancer	6.11e-05	0.000204	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—uterine cancer	6e-05	0.000201	CcSEcCtD
Pantoprazole—ABCB1—lymph node—uterine cancer	5.96e-05	0.0076	CbGeAlD
Pantoprazole—Pruritus—Epirubicin—uterine cancer	5.91e-05	0.000198	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—uterine cancer	5.72e-05	0.000191	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—uterine cancer	5.7e-05	0.000191	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—uterine cancer	5.55e-05	0.000186	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—uterine cancer	5.53e-05	0.000185	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—uterine cancer	5.47e-05	0.000183	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—uterine cancer	5.31e-05	0.000178	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—uterine cancer	5.29e-05	0.000177	CcSEcCtD
Pantoprazole—Rash—Epirubicin—uterine cancer	5.27e-05	0.000176	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—uterine cancer	5.26e-05	0.000176	CcSEcCtD
Pantoprazole—Headache—Epirubicin—uterine cancer	5.24e-05	0.000175	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—uterine cancer	5.11e-05	0.000171	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—uterine cancer	4.96e-05	0.000166	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—uterine cancer	4.92e-05	0.000164	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—uterine cancer	4.88e-05	0.000163	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—uterine cancer	4.87e-05	0.000163	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—uterine cancer	4.84e-05	0.000162	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—uterine cancer	4.59e-05	0.000154	CcSEcCtD
